Archive for ◊ March, 2010 ◊

Author:
• Wednesday, March 24th, 2010

Covidien won a patent infringement suit againstApplied Medical Resources Corp. over Applied Medical’s Kii and Universal brand laparoscopic trocars. A jury awarded Covidien $4.8 million in the suit, Bloomberg News reported. Trocars are sharp devices used to create openings for surgery or introduce tubing into the body. The suit, Tyco Healthcare Group LP and United States Surgical […]

Author:
• Wednesday, March 24th, 2010

3/22/2010 YOQNEAM, ISRAEL–(Marketwire – 03/22/10) – Given Imaging Ltd (NASDAQ:GIVN – News) today announced that it has signed a definitive agreement to acquire privately-held Sierra Scientific Instruments (Sierra Scientific) for $35 million in cash. Sierra Scientific is the leading provider of specialty diagnostic devices for the gastrointestinal (GI) tract and will become a wholly-owned subsidiary […]

Author:
• Tuesday, March 16th, 2010

The announcement of a new clinical trial, EXCEL (Evaluation of Xience Prime versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization), that will compare drug-eluting stents to coronary artery bypass graft surgery in patients with left main coronary artery disease, was made today at “Optimizing PCI Outcomes: Evolving Paradigms,” a symposium presented by […]

Author:
• Tuesday, March 16th, 2010

ATLANTA, March 15 (Reuters) – A catheter-based procedure to treat a common and potentially serious heart rhythm disorder worked better than medicine, even in patients whose disease was more advanced, researchers said on Monday. In a pilot study of an experimental St Jude Medical Inc (STJ.N) system of 60 patients with advanced atrial fibrillation, researchers […]

Author:
• Tuesday, March 16th, 2010

ePuy issued an “Urgent Field Safety Notice” on March 8, after the Australian National Joint Registry reported a higher than expected revision rate of the company’s ASR Cup and XL head used with DePuy stems in total hip replacements. Reasons for the revisions included component loosening, component malalignment, infection, pain, fracture, dislocation, and metal sensitivity. […]

Author:
• Tuesday, March 16th, 2010

MINNEAPOLIS & ALTANTA–(BUSINESS WIRE)–The consistency and quality of the long-term clinical results for the Endeavor® drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT – News), continue to distinguish it as a treatment for coronary artery disease, according to newly released data. Five-year findings from the comprehensive ENDEAVOR program were released today at ACC.10, the American […]

Author:
• Tuesday, March 16th, 2010

Boston Scientific suspends ICD sales, shares slump Mon Mar 15, 2010 3:26pm EDT Stocks Boston Scientific Corporation BSX.N $6.80 -0.98-12.60% 12:00am EDT Medtronic, Inc. MDT.N $45.81 +1.87+4.26% 12:00am EDT St. Jude Medical, Inc. STJ.N $40.56 +3.06+8.16% 12:00am EDT * Fails to submit manufacturing process changes to FDA * Company says sees no risk to patient […]

Author:
• Tuesday, March 16th, 2010

n March 4, Stryker Orthopaedics released a new total hip replacement system which, according to the company, addresses dislocation without the risk of metal ion release. The timing of the announcement was impeccable as it came a day after the New York Times ran a story about the risks associated with metal-on-metal hips. The ADM […]

Author:
• Tuesday, March 16th, 2010

t’s not going out on a limb when you’ve tested and retested…Small Bone Innovations, Inc. (SBi) has announced that after extensive evaluations by foot and ankle surgeons, it has received 510(k) pre-market clearance notifications from the FDA for Mini-Rail Fixation System (‘Mini-Rail System’) and large Cannulated Screw System for use in lower limb reconstruction and […]

Author:
• Wednesday, March 03rd, 2010

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company’s Equinoxe Platform Fracture Stem, the latest addition to the company’s […]